GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Esperion Therapeutics Inc. (ESPR) [hlAlert]

Rating:
Overweight
ESPR
down 55.22 %

Esperion Therapeutics Inc. (ESPR) rated Overweight with price target $150 by Barclays

Posted on: Thursday,  May 21, 2015  12:25 PM ET by Barclays

Barclays rated Overweight Esperion Therapeutics Inc. (NASDAQ: ESPR) on 05/21/2015, when the stock price was $116.17. Since
then, Esperion Therapeutics Inc. has lost 55.23% as of 01/05/2016's recent price of $52.01.
If you would have followed this Barclays's recommendation on ESPR, you would have lost 55.22% of your investment in 229 days.



Barclays
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
5/21/2015 12:25 PM Buy
None
116.17 150.00
as of 8/27/2015
1 Week down  -11.45 %
1 Month down  -35.76 %
3 Months down  -51.72 %
1 YTD down  -55.22 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy